3
Announcements
Trials
Browse
Landscape
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Breast Neoplasms
2
Stomach Neoplasms
1
Primary Breast Cancer
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Pancreatic Neoplasms
1
Liver Neoplasms
1
Leukemia, Myeloid, Acute
1
Leukemia, Myeloid
1
Leukemia
1
Gallbladder Neoplasms
1
Esophageal Neoplasms
1
Colonic Neoplasms
1
Biliary Tract Neoplasms
1
Interventions
Sorafenib
9
Radiofrequency Ablation
7
Oxaliplatin
7
Fluorouracil
6
Doxorubicin
6
Neoadjuvant Therapy
5
toripalimab
4
lenvatinib
4
Injections
4
Chemotherapy, Adjuvant
4
Bevacizumab
4
sintilimab
3
pembrolizumab
3
Ultrasonography
3
Thalidomide
3
Leucovorin
3
Irinotecan
3
Cisplatin
3
tislelizumab
2
durvalumab
2
camrelizumab
2
anlotinib
2
Walking Speed
2
Standard of Care
2
Radiosurgery
2
Oncolytic Virotherapy
2
Metformin
2
Liver Transplantation
2
Laparoscopy
2
Immunohistochemistry
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Liver Neoplasms
×
Anthracyclines
×
Clear all
NCT03668418
2018-09-12
xenoZ
University of Pisa
Unknown
120 enrolled